![]() | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
PMID 17638715 may be helpful for an expansion. Fvasconcellos (t·c) 16:58, 21 September 2007 (UTC)
The new insulin randomized controlled trial in NEJM (doi:10.1056/NEJMoa075392), along with the question above, raise the important point of where to discuss the trials that guide selecting a treatment regimen for diabetes? This discussion could legitimately go under Diabetes mellitus type 2, Anti-diabetic drug, or insulin. So we do not grow parallel content that is difficult to harmonize, I propose this content only go in one of these places with the other two places noting the discussion and linking to it. I would like to clarify this now before adding doi:10.1056/NEJMoa075392.
I propose this discussion go under Diabetes mellitus type 1 and Diabetes mellitus type 2, which is where most of the discussion is currently. Is this ok?
Badgettrg 20:21, 23 September 2007 (UTC)
The "Herbal extracts" section could use some expansion and better referencing. I was surprised to find no mention of Gymnema sylvestre, since it seems to be used widely, both traditionally (especially in India) and as a supplement, and a lot has been published on it (no RCTs, though). Fvasconcellos (t·c) 23:32, 19 November 2007 (UTC)
Well. Two years on, there is still no mention of Gymnema. I also find it odd that the article mentions Myrcia extracts and not Bauhinia fortificata (pata de vaca), which is arguably the most popular folk remedy for diabetes in Brazil (and for which there is ample evidence of efficacy in animal models), or Syzygium jambolanum, which is also very popular (and has been very extensively researched, although there is no clear-cut evidence to support its use). Fvasconcellos (t·c) 19:30, 18 August 2009 (UTC)
Testosterone is the most powerful and safe anti-diabetic drug and therefore I have inserted one paragraph —Preceding unsigned comment added by 158.194.199.13 (talk) 16:22, 18 October 2009 (UTC)
References
((cite journal))
: |first2=
missing |last2=
(help); |first3=
missing |last3=
(help); |first4=
missing |last4=
(help); |first5=
missing |last5=
(help); |first6=
missing |last6=
(help); |first7=
missing |last7=
(help)
((cite journal))
: |first2=
missing |last2=
(help); |first3=
missing |last3=
(help); |first4=
missing |last4=
(help)
--Doc James (talk · contribs · email) 22:02, 20 December 2009 (UTC)
It is what the articles say! if you want you may also change the sentences, but leavineg the section —Preceding unsigned comment added by 83.225.44.181 (talk) 16:02, 22 December 2009 (UTC)
Moving to this title as medication is the more accepted term Doc James (talk · contribs · email) 17:03, 9 January 2011 (UTC)
I was going to edit the comparison table to remove "effective" from the advantages of secretagogues (metformin and the glitazones typically reduce A1C just as effectively) and add "inexpensive" to metformin (it's long been off-patent). But then I saw that the table was taken directly from a published source and I'm hesitant to tweak it. Suggestions? --Yaush (talk) 15:01, 5 October 2011 (UTC)
This direct quote seems very one-sided in summing up the controversy described in its paragraph: "This weak evidence for adverse effects has reduced the use of rosiglitazone, despite its important and sustained effects on glycemic control." I did a little looking around and find that Ajjan and Grant, to whom the quote is attributed (see footnote 15), disclose a business relationship with several manufacturers of the type of drug described in the controversy. See "Disclosure" in http://spo.escardio.org/eslides/view.aspx?eevtid=33&id=5118 , which mentions consulting fees and research paid for by a number of drug manufacturers. I would think that this sentence should be removed from this article, given the article's otherwise-apparent intent of objectivity. Robtrodes (talk) 01:13, 8 November 2013 (UTC)
The hyphen should be removed from anti-diabetic in the title. The text has been edited as it was inconsistent. Just as antibiotic isn't hyphenated (nor is antihyperglycemic in the article), antidiabetic does not require hyphenation. MS Word doesn't like it, but that doesn't make it correct. The American Diabetes Association uses the nonhyphenated form. 72.1.68.18 (talk) 13:30, 9 September 2016 (UTC)KBoehm
Small sample, but they are not consistent in any way that I can see.
Antidiabetics Antidiabetic Drugs Drugs, Antidiabetic Antidiabetic Agents Agents, Antidiabetic
I am in favor of using MESH terms as much as we can so I would support switching to the unhyphenated version... What do others think? Jytdog (talk) 17:47, 9 September 2016 (UTC)
Hello fellow Wikipedians,
I have just modified one external link on Anti-diabetic medication. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template ((source check))
(last update: 5 June 2024).
Cheers.—InternetArchiveBot (Report bug) 07:56, 7 July 2017 (UTC)
Regular insulin, and so on are not rapid acting insulin. They are the modified insulins which begin to act within perhaps 15 minutes, and whose action is largely ended in something like an hour. Examples are lispro, aspart, ... This list is incorrect, and dangerously so. It should be corrected! 69.118.211.159 (talk) 10:25, 9 October 2018 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 31 May 2023 and 29 December 2023. Further details are available on the course page. Student editor(s): Sofiaebeo (article contribs).
— Assignment last updated by Sofiaebeo (talk) 21:06, 15 March 2024 (UTC)